Normoglycemic n = 1036 | Impaired fasting glucose n = 182 | Newly diagnosed type 2 diabetes mellitus n = 46 | p trend | |
---|---|---|---|---|
Age (years) | 51.7 ± 9 | 54.2 ± 8* | 54.9 ± 9 | <0.001 |
Gender (male) | 499 (51.8%) | 102 (56%) | 29 (63%)* | 0.017 |
BMI (kg/m2) | 28.2 ± 4 | 30.2 ± 4* | 30.4 ± 5* | <0.001 |
Alcohol consumption (>30 gr/day) | 18 (1.7%) | 3 (1.7%) | 2 (4.3%) | 0.610 |
Hypertension (%) | 209 (20) | 55 (30)* | 12 (26) | <0.001 |
LDL-C (mmol/l) | 3.08 ± 0.8 | 3.21 ± 0.9 | 3.10 ± 0.8 | 0.195 |
HDL-C (mmol/l) | 1.16 (0.96–1.40) | 1.05 (0.88–1.24)* | 1.04 (0.85–1.16)* | <0.001 |
Triglycerides (mmol/l) | 1.60 (1.21–2.18) | 2.01 (1.45–2.73)* | 2.29 (1.67–3.13)* | <0.001 |
Fasting glucose (mmol/l) | 4.89 (4.6–5.2) | 5.77 (5.7–6.1)* | 8.49 (7.7–12.2)*† | <0.001 |
HOMA-IR | 3.4 (2.49–4.89) | 6.16 (4.6–8.1)* | 8.98 (6.4–12)*† | <0.001 |
hsCRP (nmol/l) | 14.0 (7.52–28.6) | 21.8 (9.5–38.0)* | 21.8 (10.5–36.2)* | <0.001 |
Adipo-IR (mmol/l·μU/l) | 8.8 (5.7–13.1) | 13.3 (9.2–20)* | 12.3 (8.9–17.9)*† | <0.001 |
Free fatty acids (mmol/l) | 0.55 (0.43–0.69) | 0.57 (0.43–0.69) | 0.59 (0.52–0.76)* | 0.0312 |
Adiponectin (µg/ml)a | 8.3 (5.1–13) | 6.7 (3.9-10–2)* | 6.4 (2.8–9.2)* | <0.001 |
Subcutaneous adipose tissue (cm2) | 282 (212–360) | 307 (250–384)* | 297 (2–405)† | 0.005 |
Total adipose tissue (cm2) | 428 (3–531) | 491 (424–587)* | 502 (403–607)* | <0.001 |
Visceral adipose tissue (cm2) | 143 (105–184) | 176 (139–229)* | 177 (139–229)* | <0.001 |
Liver to spleen attenuation ratio | 1.12 (0.96–1.22) | 0.96 (0.75–1.11)* | 0.89 (0.68–1.01)* | <0.001 |